Skip to Main Content (Press Enter)

Logo UNIMORE
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills

UNI-FIND
Logo UNIMORE

|

UNI-FIND

unimore.it
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills
  1. Research Outputs

Serum naltrexone and 6-beta naltrexol concentrations in detoxified addicts during long term naltrexone treatment

Academic Article
Publication Date:
1992
Short description:
Serum naltrexone and 6-beta naltrexol concentrations in detoxified addicts during long term naltrexone treatment / Ferrari, Anna; Trenti, T; Macchia, T; Dell'Utri, A; Sternieri, E; Avico, U; Ferretti, C; Bertolotti, Marco. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - STAMPA. - 25 (Suppl 2):(1992), pp. 196-197. [10.1016/1043-6618(92)90359-J]
abstract:
The pourpose of the present study was to evaluate naltrexone and 6-b-naltrexol plasma time course during long term treatment in the usual clinical setting, in drug addicts. The plasma levels of naltrexone and 6-b-naltrexol were determined for 24 hours following an oral dose of 100 mg at the beginning and after months of naltrexone treatment. Our results showed large differences among patients in serum naltrexone and 6b-naltrexol levels. On the other hand, there were no differences in serum time course of both substances in the same patient over 3 months. Peak levels and AUCs of naltrexone were lower than those of 6b-naltrexol in 10 addicts and higher than those of the metabolite in 3 patients. No significant differences in the apparent half-lives of the two drugs were detected among groups. These data are consistent with the occurrence of a decreased first-pass metabolism of naltrexone in 3 patients leading to a larger availability of an oral dose.
Iris type:
Articolo su rivista
Keywords:
Naltrexone, 6-Beta-Naltrexol, opioid addiction, blood concentrations, first pass effect
List of contributors:
Ferrari, Anna; Trenti, T; Macchia, T; Dell'Utri, A; Sternieri, E; Avico, U; Ferretti, C; Bertolotti, Marco
Authors of the University:
BERTOLOTTI Marco
Handle:
https://iris.unimore.it/handle/11380/839892
Published in:
PHARMACOLOGICAL RESEARCH
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.4.5.0